Browse by Research Team

Research Teams (142)
- Keller, Ulrich (142)

Group by: Date | Item Type | Source

Acta Neurologica Belgica

A peculiar case of primary central nervous system T-cell lymphoma with indolent behavior.
Wasilewski, D., Janz, M. ORCID: https://orcid.org/0000-0002-1127-0044, Koch, A., Rosenwald, A., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Vajkoczy, P., Faust, K., Anagnostopoulos, I. and Radke, J. ORCID: https://orcid.org/0000-0001-9860-2007
Acta Neurologica Belgica 123 (2): 667-670. April 2022

Advanced Science

Annals of Hematology

Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia.
Tölle, M. ORCID: https://orcid.org/0000-0001-9843-2132, Gökbuget, N., Habringer, S. ORCID: https://orcid.org/0000-0002-3976-9592, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Schwartz, S. ORCID: https://orcid.org/0000-0001-8833-5793
Annals of Hematology 103 (8): 3269-3271. August 2024

Conditioning with fludarabine and treosulfan compared to FLAMSA-RIC in allogeneic stem cell transplantation for myeloid malignancies: a retrospective single-center analysis.
Braitsch, K. ORCID: https://orcid.org/0000-0003-4028-5357, Schwarz, A., Koch, K., Hubbuch, M., Menzel, H., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Götze, K.S., Bassermann, F., Herhaus, P. and Verbeek, M.
Annals of Hematology 101 (6): 1311-1319. June 2022

90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years.
Rieger, K. ORCID: https://orcid.org/0000-0002-2754-8581, De Filippi, R., Lindén, O., Viardot, A., Hess, G., Lerch, K., Neumeister, P., Stroux, A., Peuker, C.A. ORCID: https://orcid.org/0000-0002-0957-2166, Pezzutto, A. ORCID: https://orcid.org/0000-0002-3246-4470, Pinto, A., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Scholz, C.W.
Annals of Hematology 101 (4): 781-788. April 2022

First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A - results of a retrospective analysis.
Pouyiourou, M., Meyer, A., Stroux, A., Viardot, A., La Rosée, P., Maschmeyer, G., Kämpfe, D., Kahl, C., Vucinic, V., Monecke, A., Hirt, C., Weber, T., Meissner, J., Witzens-Harig, M., Böttcher, S., Schmalenberg, H., Marks, R., Prange-Krex, G., Kroschinsky, F., Hauf, E., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Koch, K., Klapper, W., Herold, M. and Scholz, C.W. ORCID: https://orcid.org/0000-0001-6260-4086
Annals of Hematology 99 (12): 2821-2829. December 2020

Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis.
Lerch, K., Meyer, A.H., Stroux, A., Hirt, C., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Viardot, A., Marks, R., Schreiber, S., Pezzutto, A. ORCID: https://orcid.org/0000-0002-3246-4470 and Scholz, C.W.
Annals of Hematology 94 (6): 981-988. June 2015

Annals of the Rheumatic Diseases

Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.
Albach, Fredrik N. ORCID: https://orcid.org/0000-0002-2697-9080, Phithak, Elpida, Biesen, Robert ORCID: https://orcid.org/0000-0002-0434-7832, Kleyer, Arnd, Siegert, Elise, Minopoulou, Ioanna, Algharably, Engi, Casteleyn, Vincent, Beenken, Anne E., Schneider, Udo, Trezzini, Sofia, Rehm, Marie, Sattler, Arne, Sinzinger, Benedikt, Wiebe, Edgar, Unterwalder, Nadine, Scholz, Veronika, Staeck, Anja, Hütter-Krönke, Marie Luise, Buttgereit, Frank, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Busse, Antonia ORCID: https://orcid.org/0000-0002-3470-6947, Krönke, Jan, Kötter, Ina, Kremer, Phillip, Exner, Tarik, Pecher, Ann-Christin, Kaudewitz, Dorothee, Sondergaard, Klaus, Troldborg, Anne, Henes, Jörg, Lorenz, Hanns-Martin, Haase, Isabell, Krusche, Martin, Krönke, Gerhard, Simon, David ORCID: https://orcid.org/0000-0001-8310-7820 and Alexander, Tobias ORCID: https://orcid.org/0000-0003-1193-0097
Annals of the Rheumatic Diseases 19 June 2026 (In Press)

Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.
Siegert, Elise, Phithak, Elpida, Albach, Fredrik N. ORCID: https://orcid.org/0000-0002-2697-9080, Biesen, Robert, Drzeniek, Norman Michael, Dzamukova, Maria, Haase, Isabell, Søndergaard, Klaus, Schleser, Dorothea, Fiebig, Leonard, Sattler, Arne, Minopoulou, Ioanna, Rehm, Marie Chiara, Kremer, Phillip, Schneider, Udo, Trezzini, Sofia, Rein, Anna Maria Claire, Mayer, Clara Marisa, Doellinger, Felix, Furth, Christian, Staeck, Anja, Cheng, Qingyu, Sinzinger, Benedikt, Unterwalder, Nadine, Ohrndorf, Sarah, Probst, Meike, Li, Yaosi, Grund, Daniel, Walter-Rittel, Thula, Fleischmann, Anja, Wiebe, Edgar, Hütter-Krönke, Marie Luise, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Krönke, Jan, Busse, Antonia ORCID: https://orcid.org/0000-0002-3470-6947, Kleyer, Arnd, Pecher, Ann-Christin, Henes, Jörg, Troldborg, Anne, Hauser, Anja Erika, Kötter, Ina, Krusche, Martin, Krönke, Gerhard, Alexander, Tobias ORCID: https://orcid.org/0000-0003-1193-0097 and Simon, David
Annals of the Rheumatic Diseases 18 June 2026 (In Press)

Teclistamab-induced rapid remission in refractory anti-Jo-1 antisynthetase syndrome.
Phithak, Elpida, Albach, Fredrik N., Minopoulou, Ioanna, Biesen, Robert, Kleyer, Arnd, Wiebe, Edgar, Siegert, Elise, Scholz, Veronika, Rehm, Marie, Cheng, Qingyu, Sattler, Arne, Bianco, Stefano, Fleischmann, Anja, Hermann, Kay-Geert, Walter-Rittel, Thula, Wagner, Moritz, Zernicke, Jan, Casteleyn, Vincent, Nielsen, Martin, Rose, Thomas, Busse, Antonia ORCID: https://orcid.org/0000-0002-3470-6947, Hütter-Krönke, Marie Luise, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Schneider, Udo, Kawelke, Leona, Ruffer, Nikolas, Stenzel, Werner, Krönke, Gerhard, Simon, David ORCID: https://orcid.org/0000-0001-8310-7820 and Alexander, Tobias
Annals of the Rheumatic Diseases 85 (1): 212-215. January 2026

BMC Infectious Diseases

Anti-SARS-CoV2 antibody-mediated cytokine release syndrome in a patient with acute promyelocytic leukemia.
Hegazy, A.N. ORCID: https://orcid.org/0000-0002-2946-8251, Krönke, J., Angermair, S., Schwartz, S., Weidinger, C., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Treskatsch, S., Siegmund, B. and Schneider, T.
BMC Infectious Diseases 22 (1): 537. 13 June 2022

Biomedicines

Authentication of primary murine cell lines by a microfluidics-based lab-on-chip system.
Hong, Y., Singh, N., Bamopoulos, S., Gjerga, E., Schmalbrock, L.K. ORCID: https://orcid.org/0000-0002-6080-6175, Balabanian, K. ORCID: https://orcid.org/0000-0002-0534-3198, Schick, M. ORCID: https://orcid.org/0009-0003-8626-0611, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Wirth, M. ORCID: https://orcid.org/0000-0002-8340-0872
Biomedicines 8 (12): 590. 9 December 2020

Blood

Clonal hematopoiesis and lymphoma-associated mutations in hematopoietic progenitors in B-cell non-Hodgkin lymphoma.
Wiegand, Laura, Silva, Patricia, Noerenberg, Daniel, Christen, Friederike, Kopp, Klara, Locher, Benjamin Nick, Löwe, Pelle, Tilgner, Marlon, Altwasser, Robert ORCID: https://orcid.org/0009-0002-6216-6068, Storzer, Vanessa, Stein, Catarina Marlene, Briest, Franziska, Arends, Christopher Maximilian, Frick, Mareike, Ihlow, Jana, Dolnik, Anna, Ishaque, Naveed ORCID: https://orcid.org/0000-0002-8426-901X, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Na, Il-Kang ORCID: https://orcid.org/0000-0001-9902-5424, Penter, Livius ORCID: https://orcid.org/0000-0002-9060-0207, Bullinger, Lars ORCID: https://orcid.org/0000-0002-5890-5510, Hablesreiter, Raphael and Damm, Frederik
Blood 147 (15): 1723-1734. 9 April 2026

Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022.
Baumgartner, F. ORCID: https://orcid.org/0000-0003-0768-1956, Baer, C., Bamopoulos, S.A. ORCID: https://orcid.org/0000-0002-5997-7735, Ayoub, E. ORCID: https://orcid.org/0000-0003-1321-0114, Truger, M., Meggendorfer, M., Lenk, M., Hoermann, G., Hutter, S. ORCID: https://orcid.org/0000-0003-2432-8898, Müller, H., Walter, W. ORCID: https://orcid.org/0000-0002-5083-9838, Mueller, M.L., Nadarajah, Ni., Blombery, P., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Kern, W., Haferlach, C. and Haferlach, T.
Blood 143 (12): 1139-1156. 21 March 2024

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Schmitz, N., Truemper, L.H., Bouabdallah, K., Ziepert, M., Leclerc, M., Cartron, G., Jaccard, A., Reimer, P., Wagner-Drouet, E.M., Wilhelm, M., Sanhes, L., Lamy, T., de Leval, L., Rosenwald, A., Roussel, M., Kroschinsky, F.P., Lindemann, W.W., Dreger, P., Viardot, A., Milpied, N.J., Gisselbrecht, C., Wulf, G.G., Gyan, E., Gaulard, P., Bay, J.O., Glass, B., Poeschel, V., Damaj, G., Sibon, D., Delmer, A.J., Bilger, K., Banos, A., Haenel, M., Dreyling, M., Metzner, B., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Braulke, F., Friedrichs, B., Nickelsen, M., Altmann, B. and Tournilhac, O.
Blood 137 (19): 2646-2656. 13 May 2021

Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.
Reinke, S., Bröckelmann, P.J., Iaccarino, I., Garcia-Marquez, M., Borchmann, S., Jochims, F., Kotrova, M., Pal, K., Brüggemann, M., Hartmann, E., Sasse, S., Kobe, C., Mathas, S. ORCID: https://orcid.org/0000-0001-9626-1413, Soekler, M., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Bormann, M., Zimmermann, A., Richter, J., Fuchs, M., von Tresckow, B., Borchmann, P., Schlößer, H., von Bergwelt-Baildon, M., Rosenwald, A., Engert, A. and Klapper, W.
Blood 136 (25): 2851-2863. 17 December 2020

Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.
Hoellein, A., Fallahi, M., Schoeffmann, S., Steidle, S., Schaub, F.X., Rudelius, M., Laitinen, I., Nilsson, L., Goga, A., Peschel, C., Nilsson, J.A., Cleveland, J.L. and Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958
Blood 124 (13): 2081-2090. 25 September 2014

Blood Advances

SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma.
Heynen, G.J.J.E., Baumgartner, F. ORCID: https://orcid.org/0000-0003-0768-1956, Heider, M., Patra, U., Holz, M., Braune, J., Kaiser, M., Schäffer, I., Bamopoulos, S.A., Ramberger, E. ORCID: https://orcid.org/0000-0003-2760-2696, Murgai, A., Ng, Y.L.D., Demel, U.M. ORCID: https://orcid.org/0000-0002-6480-4185, Laue, D., Liebig, S., Krüger, J., Janz, M. ORCID: https://orcid.org/0000-0002-1127-0044, Nogai, A., Schick, M. ORCID: https://orcid.org/0009-0003-8626-0611, Mertins, P. ORCID: https://orcid.org/0000-0002-2245-528X, Müller, S., Bassermann, F., Krönke, J., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Wirth, M.
Blood Advances 7 (4): 469-481. 28 February 2023

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma.
Stroh, J., Seckinger, A. ORCID: https://orcid.org/0000-0002-2771-712X, Heider, M., Rudelius, M., Eichner, R. ORCID: https://orcid.org/0000-0002-8433-9452, Schick, M. ORCID: https://orcid.org/0009-0003-8626-0611, Slawska, J., Emde, M., Salwender, H., Bertsch, U., Goldschmidt, H. ORCID: https://orcid.org/0000-0003-0961-0035, Weisel, K.C., Scheid, C., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Hose, D. and Bassermann, F.
Blood Advances 6 (2): 515-520. 25 January 2022

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas.
Liebers, N., Duell, J., Fitzgerald, D. ORCID: https://orcid.org/0000-0003-4927-7484, Kerkhoff, A., Noerenberg, D., Kaebisch, E. ORCID: https://orcid.org/0000-0001-7752-4126, Acker, F. ORCID: https://orcid.org/0000-0002-6207-0237, Fuhrmann, S. ORCID: https://orcid.org/0000-0002-7785-2565, Leng, C., Welslau, M., Chemnitz, J., Middeke, J.M., Weber, T. ORCID: https://orcid.org/0000-0002-8724-9348, Holtick, U., Trappe, R., Pfannes, R., Liersch, R., Spoer, C., Fuxius, S., Gebauer, N., Caillé, L., Geer, T., Koenecke, C. ORCID: https://orcid.org/0000-0001-7025-1735, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Claus, R. ORCID: https://orcid.org/0000-0003-2617-8766, Mougiakakos, D., Mayer, S., Huettmann, A. ORCID: https://orcid.org/0000-0003-2230-3873, Pott, C., Trummer, A., Wulf, G., Brunnberg, U., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Hess, G., Mueller-Tidow, C., Glass, B., Lenz, G., Dreger, P. and Dietrich, S.
Blood Advances 5 (13): 2707-2716. 13 July 2021

Blood Cancer Discovery

Outcomes of CAR-T cell therapy and bispecific antibodies as single-modality and sequential strategies in relapsed/refractory multiple myeloma.
Merz, Maximilian, Jelinek, Tomas, Pabst, Thomas, Teipel, Raphael, Albici, Anca-Maria, von Tresckow, Bastian, Teichert, Marcel, Demel, Uta Margareta ORCID: https://orcid.org/0000-0002-6480-4185, Busse, Antonia ORCID: https://orcid.org/0000-0002-3470-6947, Wesener, Marie Christine, Holderried, Tobias A.W., Schmitz, Friederike, Rößiger, Friedrich-Linus, Müller, Fabian, Hoffmann, Michele, Stölzel, Friedrich, Tovar, Natalia, Baermann, Ben-Niklas, Stork, Martin, Jungova, Alexandra, Minarik, Jiri, Radocha, Jakub, Spicka, Ivan, Pour, Ludek, Novak, Polona, Slajpah, Klara, Rener, Karla, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Bohl, Stephan, Fandrei, David, Born, Patrick, Vucinic, Vladan, Kröger, Nicolaus, Strassl, Irene, Schub, Natalie, Hájek, Roman, Sever, Matjaz, Fernández de Larrea, Carlos and Gagelmann, Nico
Blood Cancer Discovery 12 June 2026 (In Press)

Blood Cancer Journal

Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy.
Gross, S., Ihlow, J. ORCID: https://orcid.org/0000-0001-5484-1321, Busack, L., Adamiak, K., Schrezenmeier, J. ORCID: https://orcid.org/0000-0001-5239-4513, Jesse, J., Schwarz, M., Flörcken, A., Vuong, L.G., Rieger, K., Krönke, J. ORCID: https://orcid.org/0000-0002-4649-0506, le Coutre, P., Boldt, V., von Brünneck, A.C., Horst, D., Burmeister, T. ORCID: https://orcid.org/0000-0003-4843-2876, Blau, I.W., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510 and Westermann, J.
Blood Cancer Journal 14 (1): 160. 16 September 2024

Blood Immunology & Cellular Therapy

Bone Marrow Transplantation

British Journal of Cancer

The SUMO pathway in pancreatic cancer: insights and inhibition.
Schneeweis, C., Hassan, Z. ORCID: https://orcid.org/0000-0002-7981-8328, Schick, M. ORCID: https://orcid.org/0009-0003-8626-0611, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Schneider, G. ORCID: https://orcid.org/0000-0003-1840-4508
British Journal of Cancer 124 (3): 531-538. 2 February 2021

British Journal of Haematology

A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial.
Hess, G. ORCID: https://orcid.org/0000-0002-9282-5688, Hüttmann, A. ORCID: https://orcid.org/0000-0003-2230-3873, Witzens-Harig, M., Dreyling, M.H., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Marks, R., Ernst, T., Pott, C., Viardot, A., Frontzek, F., Trautmann, M., Ruckes, C., Deuster, O., Rosenwald, A., Theobald, M. and Lenz, G.
British Journal of Haematology 198 (3): 482-491. 1 April 2022

British Journal of Pharmacology

A comprehensive review of cancer-induced cardiac wasting.
Lena, Alessia, Khan, Muhammad Shahzeb, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Bullinger, Lars ORCID: https://orcid.org/0000-0002-5890-5510, Modest, Dominik P. and Anker, Markus S.
British Journal of Pharmacology 22 April 2026 (In Press)

Cancer & Metabolism

Pressure-adjusted static compression: aerobic metabolism and microvascular perfusion in the context of chemotherapy-induced neuropathy.
Lischke, Betty, Mohammad, Josef, Rheimann, René, Schraplau, Anne, Haspel, Antonia, Schmidt-Lucke, André, Ochsenreither, Sebastian, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Habazettl, Helmut and Schmidt-Lucke, Caroline
Cancer & Metabolism 13 (1): 40. December 2025

Cancer Cell

Age-related gliosis promotes central nervous system lymphoma through CCL19-mediated tumor cell retention.
O'Connor, T., Zhou, X., Kosla, J., Adili, A., Garcia Beccaria, M., Kotsiliti, E., Pfister, D., Johlke, A.L., Sinha, A., Sankowski, R., Schick, M. ORCID: https://orcid.org/0009-0003-8626-0611, Lewis, R., Dokalis, N., Seubert, B., Höchst, B., Inverso, D., Heide, D., Zhang, W., Weihrich, P., Manske, K., Wohlleber, D., Anton, M., Hoellein, A., Seleznik, G., Bremer, J., Bleul, S., Augustin, H.G., Scherer, F., Koedel, U., Weber, A., Protzer, U., Förster, R., Wirth, T., Aguzzi, A., Meissner, F., Prinz, M., Baumann, B., Höpken, U.E. ORCID: https://orcid.org/0000-0002-0776-4893, Knolle, P.A., von Baumgarten, L., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Heikenwalder, M.
Cancer Cell 36 (3): 250-267. 16 September 2019

Cancer Research

A hypoxia-epigenetics axis drives EMT in pancreatic cancer.
Wirth, M. ORCID: https://orcid.org/0000-0002-8340-0872 and Schneider, G. ORCID: https://orcid.org/0000-0003-1840-4508
Cancer Research 84 (11): 1739-1741. 1 June 2024

Cancers

Spontaneous non-sustained ventricular tachycardia and premature ventricular contractions and their prognostic relevance in patients with cancer in routine care.
Albrecht, A., Porthun, J. ORCID: https://orcid.org/0000-0002-4100-4361, Eucker, J., Coats, A.J.S., von Haehling, S., Pezzutto, A. ORCID: https://orcid.org/0000-0002-3246-4470, Karakas, M. ORCID: https://orcid.org/0000-0002-5715-2959, Riess, H., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Landmesser, U., Haverkamp, W., Anker, S.D. and Anker, M.S.
Cancers 13 (10): 2303. 12 May 2021

ECG scoring for the evaluation of therapy-naïve cancer patients to predict cardiotoxicity.
Pohl, J. ORCID: https://orcid.org/0000-0001-9142-4869, Mincu, R.I., Mrotzek, S.M., Wakili, R., Mahabadi, A.A. ORCID: https://orcid.org/0000-0003-2336-7991, Potthoff, S.K., Siveke, J.T. ORCID: https://orcid.org/0000-0002-8772-4778, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Landmesser, U., Rassaf, T. ORCID: https://orcid.org/0000-0001-8001-0265, Anker, M.S. and Totzeck, M.
Cancers 13 (6): 1197. 10 March 2021

Ubiquitination and ubiquitin-like modifications in multiple myeloma: biology and therapy.
Wirth, M. ORCID: https://orcid.org/0000-0002-8340-0872, Schick, M. ORCID: https://orcid.org/0009-0003-8626-0611, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Krönke, J.
Cancers 12 (12): 3764. 14 December 2020

Case Reports in Hematology

Renal extramedullary hematopoiesis in mast cell leukemia with bone marrow fibrosis.
Rieke, D.T. ORCID: https://orcid.org/0000-0003-0027-7977, Schmalbrock, L.K. ORCID: https://orcid.org/0000-0002-6080-6175, Ihlow, J. ORCID: https://orcid.org/0000-0001-5484-1321, Kleo, K. ORCID: https://orcid.org/0000-0001-9136-6902, von Brünneck, A.C. ORCID: https://orcid.org/0000-0003-4371-4292, Nolte, F., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Ochsenreither, S. ORCID: https://orcid.org/0000-0001-6024-4312
Case Reports in Hematology 2024 : 1-6. 3 January 2024

Relapse of NPM1-mutated AML with extramedullary manifestation 17 years after allogeneic hematopoietic stem cell transplantation.
Braune, J. ORCID: https://orcid.org/0000-0003-2026-2641, Rieger, K., Blau, O. ORCID: https://orcid.org/0000-0002-4304-5079, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510 and Krönke, J.
Case Reports in Hematology 2022 : 3317936. 28 December 2022

Cell Death Discovery

Integrated real-time imaging of executioner caspase dynamics, apoptosis-induced proliferation, and immunogenic cell death using a stable fluorescent reporter platform.
Selcen, Selen ORCID: https://orcid.org/0009-0006-4006-4369, Wieland, Lena ORCID: https://orcid.org/0009-0006-5969-1012, De Oliveira, Tiago ORCID: https://orcid.org/0000-0002-2502-7897, Ghadimi, Michael, Conradi, Lena-Christin, Schneider, Günter ORCID: https://orcid.org/0000-0003-1840-4508, Witte, Leonie ORCID: https://orcid.org/0000-0003-2154-937X and Wirth, Matthias ORCID: https://orcid.org/0000-0002-8340-0872
Cell Death Discovery 11 (1): 368. 6 August 2025

Clinical Cancer Research

Early response to first-line anti-PD-1 treatment in Hodgkin lymphoma: a PET-based analysis from the prospective, randomized phase II NIVAHL trial.
Voltin, C.A., Mettler, J., van Heek, L., Goergen, H., Müller, H., Baues, C., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Meissner, J., Trautmann-Grill, K., Kerkhoff, A., Fuchs, M., Sasse, S., von Tresckow, B., Dietlein, M., Borchmann, P., Engert, A., Kobe, C. and Bröckelmann, P.J.
Clinical Cancer Research 27 (2): 402-407. January 2021

Clinical Chemistry and Laboratory Medicine

Simplified preanalytical laboratory procedures for therapeutic drug monitoring (TDM) in patients treated with high-dose methotrexate (HD-MTX) and glucarpidase.
Knörnschild, F.L. ORCID: https://orcid.org/0009-0004-6437-9774, Liebig, S. ORCID: https://orcid.org/0000-0002-5494-8476, Kießling, P., Prpic, M. ORCID: https://orcid.org/0009-0006-3730-5037, Kim, T., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Kappert, K. ORCID: https://orcid.org/0000-0001-6976-0428, Schwartz, S. ORCID: https://orcid.org/0000-0001-8833-5793 and Jahic, A. ORCID: https://orcid.org/0000-0001-8318-0147
Clinical Chemistry and Laboratory Medicine 63 (1): e11-e15. 2025

Clinical Research in Cardiology

Association of an impaired GH‑IGF‑I axis with cardiac wasting in patients with advanced cancer.
Fröhlich, A.K., Porthun, J., Talha, K.M., Lena, A., Hadzibegovic, S., Wilkenshoff, U., Sonntag, F., Nikolski, A., Ramer, L.V., Zeller, T., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Anker, S.D., Haverkamp, W., von Haehling, S., Doehner, W., Rauch, U., Skurk, C., Cleland, J.G.F., Butler, J., Coats, A.J.S., Landmesser, U., Karakas, M. and Anker, M.S. ORCID: https://orcid.org/0000-0002-4406-8555
Clinical Research in Cardiology 114 (9): 1118-1132. September 2025

Assessment of coronary artery disease during hospitalization for cancer treatment.
Mrotzek, S.M., Lena, A., Hadzibegovic, S., Ludwig, R., Al-Rashid, F., Mahabadi, A.A., Mincu, R.I., Michel, L., Johannsen, L., Hinrichs, L., Schuler, M., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Anker, S.D., Landmesser, U., Rassaf, T., Anker, M.S. and Totzeck, M.
Clinical Research in Cardiology 110 (2): 200-210. February 2021

EJNMMI Research

Influence of corticosteroid treatment on CXCR4 expression in DLBCL.
Martin, S., Viertl, D., Janz, A., Habringer, S. ORCID: https://orcid.org/0000-0002-3976-9592, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Schottelius, M. ORCID: https://orcid.org/0000-0002-1928-6913
EJNMMI Research 13 (1): 40. 10 May 2023

Rationale for MYC imaging and targeting in pancreatic cancer.
Schneider, G. ORCID: https://orcid.org/0000-0003-1840-4508, Wirth, M. ORCID: https://orcid.org/0000-0002-8340-0872, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Saur, D.
EJNMMI Research 11 (1): 104. 12 October 2021

Investigation of spleen CXCR4 expression by [(68)Ga]Pentixafor PET in a cohort of 145 solid cancer patients.
Lewis, R., Habringer, S. ORCID: https://orcid.org/0000-0002-3976-9592, Kircher, M., Hefter, M., Peuker, C.A. ORCID: https://orcid.org/0000-0002-0957-2166, Werner, R., Ademaj-Kospiri, V., Gäble, A., Weber, W., Wester, H.J., Buck, A., Herhaus, P., Lapa, C. and Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958
EJNMMI Research 11 (1): 77. 21 August 2021

EMBO Journal

The OTUD6B-LIN28B-MYC axis determines the proliferative state in multiple myeloma.
Paulmann, C., Spallek, R., Karpiuk, O., Heider, M., Schäffer, I., Zecha, J. ORCID: https://orcid.org/0000-0002-8767-6294, Klaeger, S., Walzik, M., Öllinger, R. ORCID: https://orcid.org/0000-0002-2292-5982, Engleitner, T., Wirth, M. ORCID: https://orcid.org/0000-0002-8340-0872, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Krönke, J., Rudelius, M., Kossatz, S., Rad, R. ORCID: https://orcid.org/0000-0002-6849-9659, Kuster, B. ORCID: https://orcid.org/0000-0002-9094-1677 and Bassermann, F. ORCID: https://orcid.org/0000-0003-4435-2609
EMBO Journal 41 (20): e110871. 17 October 2022

EMBO Molecular Medicine

In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.
Philipp-Abbrederis, K., Herrmann, K., Knop, S., Schottelius, M., Eiber, M., Lückerath, K., Pietschmann, E., Habringer, S., Gerngroß, C., Franke, K., Rudelius, M., Schirbel, A., Lapa, C., Schwamborn, K., Steidle, S., Hartmann, E., Rosenwald, A., Kropf, S., Beer, A.J., Peschel, C., Einsele, H., Buck, An.K., Schwaiger, M., Götze, K., Wester, H.J. and Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958
EMBO Molecular Medicine 7 (4): 477-487. 1 April 2015

ERJ Open Research

High-dose glucocorticoid treatment of near-fatal Bocavirus lung infection results in rapid recovery.
Obenaus, M. ORCID: https://orcid.org/0000-0002-5090-9162, Schildgen, O., Schürmann, D., von Brünneck, A.C., Janz, M. ORCID: https://orcid.org/0000-0002-1127-0044, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Gebauer, B., Schilling, J., Schwartz, S. ORCID: https://orcid.org/0000-0001-8833-5793, Weissbrich, B., Schneider, T., Hofmann, J. and Mathas, S. ORCID: https://orcid.org/0000-0001-9626-1413
ERJ Open Research 7 (2): 00060-2021. 12 April 2021

ESC Heart Failure

Cardiovascular and metabolic determinants of quality of life in patients with cancer.
Evertz, R. ORCID: https://orcid.org/0000-0002-5904-4652, Gödde, K., Diehl, C., Valentova, M., Garfias-Veitl, T., Braulke, F., Wulf, G.G., Overbeck, T.R., Bleckmann, A., König, A.O., Weinländer, P., Potthoff, S., Hadzibegovic, S., Lena, A., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Landmesser, U., Schuster, A. ORCID: https://orcid.org/0000-0003-1508-1125, Anker, M.S., Hasenfuß, G. and von Haehling, S. ORCID: https://orcid.org/0000-0002-9818-042X
ESC Heart Failure 10 (1): 167-176. February 2023

ESMO Open

Implementation and outcome of personalized treatment strategies in advanced genitourinary cancers.
Klostermann, A., Debertshäuser, T., Benary, M. ORCID: https://orcid.org/0000-0002-3067-2030, Biernath, N., Erber, B., Tahbaz, R., Möbs, M., Joosten, M., Schmitt, W.D., Kim, T., Jelas, I., Chai, L., Jegodka, Y., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Beule, D. ORCID: https://orcid.org/0000-0002-3284-0632, Ochsenreither, S., De Santis, M., Schlomm, T., Keilholz, U., Knödler, M. and Rieke, D.T.
ESMO Open 10 (7): 105497. July 2025

European Heart Journal

Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial).
Anker, Markus S. ORCID: https://orcid.org/0000-0002-4406-8555, Mahabadi, Amir A., Totzeck, Matthias, Tewes, Mitra, Shahzeb Khan, Muhammad, Mincu, Raluca I., Hendgen-Cotta, Ulrike B., Michel, Lars, Mathew, Baicy, Drescher, Ophelia, Schuler, Martin, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Rieger, Kathrin, Ahn, Johann, Bullinger, Lars ORCID: https://orcid.org/0000-0002-5890-5510, Modest, Dominik P., Denecke, Corinna, Kretzler, Lucie, Ramer, Luisa V., Krug, Danara, Landmesser, Ulf, Lehmann, Lorenz, Frey, Norbert, Bercker, Sven, Laufs, Ulrich, Böhm, Michael, Mahfoud, Felix ORCID: https://orcid.org/0000-0002-4425-549X, Merkely, Bela, Diek, Monika, Butler, Javed, Veiser, Anja, Heise, Tim, Hellmich, Martin, Placzek, Marius, Friede, Tim ORCID: https://orcid.org/0000-0001-5347-7441, Anker, Stefan D. and Rassaf, Tienush
European Heart Journal 47 (9): 1034-1046. 1 March 2026

European Journal of Cancer

Characterizing uveal melanoma patients with peritoneal metastases: a retrospective single-center analysis.
Rosnev, S. ORCID: https://orcid.org/0000-0003-0256-7038, Peuker, C.A. ORCID: https://orcid.org/0000-0002-0957-2166, Piwonski, I., Ihlow, J., Leyvraz, S., Klingberg, J., Horst, D., Joosten, M., Möbs, M., Joussen, A.M., de Bucourt, M., Keilholz, U., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Ochsenreither, S. and Rittig, S.M.
European Journal of Cancer 218 : 115280. 11 March 2025

Tumour mutational burden and survival with molecularly matched therapy.
de Bortoli, T., Benary, M. ORCID: https://orcid.org/0000-0002-3067-2030, Horak, P., Lamping, M., Stintzing, S., Tinhofer, I., Leyvraz, S., Schäfer, R., Klauschen, F., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Stenzinger, A., Fröhling, S., Kurzrock, R., Keilholz, U., Rieke, D.T. and Jelas, I.
European Journal of Cancer 190 : 112925. September 2023

European Journal of Heart Failure

Clinical and echocardiographic phenotype of cardiac wasting in patients with advanced cancer.
Anker, Markus S. ORCID: https://orcid.org/0000-0002-4406-8555, Khan, Muhammad Shahzeb, Nikolski, Anja, Porthun, Jan, Arshad, Muhammad Sameer, Hadzibegovic, Sara, Lena, Alessia, Kretzler, Lucie, Hella, Jonathan L., Witkowski, Marco, Rieger, Kathrin, Ahn, Johann, Modest, Dominik P., Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Bullinger, Lars ORCID: https://orcid.org/0000-0002-5890-5510, Totzeck, Matthias, Mahabadi, Amir A., Rassaf, Tienush, Buchmann, Nikolaus, Attanasio, Philipp, Zeller, Tanja, Karakas, Mahir, Tocchetti, Carlo G., Wilkenshoff, Ursula, Cleland, John G.F., von Haehling, Stephan, Butler, Javed and Landmesser, Ulf
European Journal of Heart Failure 27 (11): 2130-2140. November 2025

Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: rationale and design of the EMPATICC trial.
Anker, Markus S. ORCID: https://orcid.org/0000-0002-4406-8555, Mahabadi, Amir A., Totzeck, Matthias, Tewes, Mitra, Mincu, Raluca, Khan, Muhammad Shahzeb, Butler, Javed, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Ahn, Johann, Bullinger, Lars ORCID: https://orcid.org/0000-0002-5890-5510, Modest, Dominik P., Landmesser, Ulf, Lehmann, Lorenz H., Bercker, Sven, Laufs, Ulrich, Böhm, Michael, Merkely, Bela, Diek, Monika, Heise, Tim, Hellmich, Martin, Placzek, Marius, Friede, Tim ORCID: https://orcid.org/0000-0001-5347-7441, Anker, Stefan D. and Rassaf, Tienush
European Journal of Heart Failure 27 (10): 1905-1917. October 2025

New cardiovascular biomarkers in patients with advanced cancer – a prospective study comparing MR-proADM, MR-proANP, copeptin, high-sensitivity troponin T and NT-proBNP.
Anker, M.S. ORCID: https://orcid.org/0000-0002-4406-8555, Lück, L.C., Khan, M.S., Porthun, J., Hadzibegovic, S., Lena, A., Wilkenshoff, U., Weinländer, P., Evertz, R., Totzeck, M., Mahabadi, A.A., Rassaf, T., Anker, S.D. ORCID: https://orcid.org/0000-0002-4406-8555, Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Karakas, M., Landmesser, U., Butler, J. and von Haehling, S.
European Journal of Heart Failure 27 (6): 1047-1055. June 2025

Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire.
Anker, M.S., Potthoff, S.K., Lena, A., Porthun, J., Hadzibegovic, S., Evertz, R., Denecke, C., Fröhlich, A.K., Sonntag, F., Regitz-Zagrosek, V., Rosen, S.D., Lyon, A.R., Lüscher, T.F., Spertus, J.A., Anker, S.D., Karakas, M., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Landmesser, U., Butler, J. and von Haehling, S.
European Journal of Heart Failure 25 (9): 1635-1647. September 2023

Frontiers in Oncology

Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma.
Rieke, D.T., Schröder, S., Schafhausen, P., Blanc, E. ORCID: https://orcid.org/0000-0002-4369-0254, Zuljan, E., von der Emde, B., Beule, D. ORCID: https://orcid.org/0000-0002-3284-0632, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Keilholz, U. and Klinghammer, K. ORCID: https://orcid.org/0000-0001-6425-4833
Frontiers in Oncology 13 : 1107134. 2023

Survey of long-term experiences of sperm cryopreservation in oncological and non-oncological patients: usage and reproductive outcomes of a large monocentric cohort.
Lackamp, N., Wilkemeyer, I., Jelas, I., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Stintzing, S. and le Coutre, P.
Frontiers in Oncology 11 : 772809. 5 November 2021

Gastroenterology

Targeting mutual dependence of phosphatidylinositol-3-kinase α/δ and small ubiquitin-like modifier signaling in pancreatic cancer.
Köse, Hazal, Schneeweis, Christian, Putze, Philipp, Contreras, Constanza Tapia, Ferreiro, Laura, Witte, Leonie, Deidda, Ilaria, Herzberg, Frederik, Ebert, Sophie, Jakubik, Juraj, Moldaner, Leoni, Todorovic, Jovan, Träger, Isabelle, Zang, Chuanbing, Demel, Uta M. ORCID: https://orcid.org/0000-0002-6480-4185, Hessmann, Elisabeth, Kirchner, Marieluise ORCID: https://orcid.org/0000-0002-7049-534X, Rhein, Simone ORCID: https://orcid.org/0000-0002-9445-2352, Hoffmann, Jens ORCID: https://orcid.org/0000-0003-3880-1658, Tatarova, Zuzana, Ghadimi, Michael, Saur, Dieter, Kappert, Kai, Mertins, Philipp ORCID: https://orcid.org/0000-0002-2245-528X, Schneider, Günter, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958 and Wirth, Matthias ORCID: https://orcid.org/0000-0002-8340-0872
Gastroenterology 170 (2): 315-329. February 2026

Gene Expression Omnibus (GEO)

Genetic alterations of SENP6 disrupt DNA repair and proteostasis conferring sensitivity to proteasome inhibition in multiple myeloma.
Herzberg, F., Korenkov, M. ORCID: https://orcid.org/0000-0002-2988-8483, Isaakidis, K., Zang, C., Wirth, M. ORCID: https://orcid.org/0000-0002-8340-0872, Müller, S., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Demel, U.M. ORCID: https://orcid.org/0000-0002-6480-4185
[Dataset] 8 December 2025

Global Cardiology

Optimized HF therapy in patients with advanced cancer in palliative care: dosing strategies from the EMPATICC trial.
Anker, Markus S., Shahzeb Khan, Muhammad, Mahabadi, Amir A., Totzeck, Matthias, Tewes, Mitra, Arshad, Muhammad Sameer, Mincu, Raluca, Butler, Javed, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Ahn, Johann, Bullinger, Lars ORCID: https://orcid.org/0000-0002-5890-5510, Modest, Dominik P., Landmesser, Ulf, Lehmann, Lorenz H., Bercker, Sven, Laufs, Ulrich, Böhm, Michael, Merkely, Bela, Diek, Monika, Heise, Tim, Hellmich, Martin, Placzek, Marius, Friede, Tim, Anker, Stefan D. and Rassaf, Tienush
Global Cardiology 3 (3): 3-9. 30 September 2025

Gut

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.
Biederstädt, A., Hassan, Z., Schneeweis, C., Schick, M. ORCID: https://orcid.org/0009-0003-8626-0611, Schneider, L., Muckenhuber, A., Hong, Y., Siegers, G., Nilsson, L., Wirth, M., Dantes, Z., Steiger, K., Schunck, K., Langston, S., Lenhof, H.P., Coluccio, A., Orben, F., Slawska, J., Scherger, A., Saur, D., Müller, S., Rad, R., Weichert, W., Nilsson, J., Reichert, M. ORCID: https://orcid.org/0000-0002-8611-5639, Schneider, G. ORCID: https://orcid.org/0000-0003-1840-4508 and Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958
Gut 69 (8): 1472-1482. August 2020

Haematologica

Genetic alterations of SENP6 in multiple myeloma disrupt genome and proteome stability, sensitizing to proteasome inhibition.
Herzberg, Frederik, Korenkov, Michael ORCID: https://orcid.org/0000-0002-2988-8483, Isaakidis, Konstandina, Zang, Chuanbing, Wirth, Matthias ORCID: https://orcid.org/0000-0002-8340-0872, Müller, Stefan, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958 and Demel, Uta M. ORCID: https://orcid.org/0000-0002-6480-4185
Haematologica 111 (5): 1828-1834. May 2026

Chemotherapy-free combination of ibrutinib and obinutuzumab for untreated advanced follicular lymphoma: results of a phase II study from the German Lymphoma Alliance.
Schmidt, Christian, Scheubeck, Gabriel, Jurinovic, Vindi, Sökler, Martin, Forstpointner, Roswitha, Buske, Christian, Viardot, Andreas, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Graeven, Ullrich, Marks, Reinhard, Hänel, Mathias, Liersch, Rüdiger, Dürig, Jan, Pott, Christiane, Hoster, Eva, Unterhalt, Michael and Hiddemann, Wolfgang
Haematologica 110 (12): 3022-3031. 1 December 2025

A phase I study of MAGE-A1-targeted T1367 T-cell receptor-based cell therapy in patients with advanced multiple myeloma.
Krüger, J., Obenaus, M. ORCID: https://orcid.org/0000-0002-5090-9162, Blau, I.W., Hoser, D., Vaegler, M. ORCID: https://orcid.org/0009-0005-3852-4525, Rauschenbach, H., Anagnostopoulos, I., Jöhrens, K., Scheuplein, V., Kieback, E. ORCID: https://orcid.org/0000-0003-3831-2846, Böhme, J., Von Brünneck, A.C., Krönke, J., Busse, A. ORCID: https://orcid.org/0000-0002-3470-6947, Willimsky, G. ORCID: https://orcid.org/0000-0002-9693-948X, Blankenstein, T. ORCID: https://orcid.org/0000-0002-3357-4321, Pezzutto, A. ORCID: https://orcid.org/0000-0002-3246-4470, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Nogai, A.
Haematologica 110 (1): 244-250. January 2025

Frequent, high density expression of surface CD38 as a potential therapeutic target in adult T-lineage acute lymphoblastic leukemia.
Koslowski, S., Glauben, R., Habringer, S. ORCID: https://orcid.org/0000-0002-3976-9592, Burmeister, T., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Brüggemann, M., Gökbuget, N. and Schwartz, S.
Haematologica 109 (2): 661-665. February 2024

Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Kayser, S., Martínez-Cuadrón, D., Rodriguez-Veiga, R., Hänel, M., Tormo, M., Schäfer-Eckart, K., Botella, C., Stölzel, F., Del Castillo, T.B., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Rodriguez-Medina, C., Held, G., Amigo, M.L., Schliemann, C., Colorado, M., Kaufmann, M., Garcia, M.B., Krause, S.W., Görner, M., Jost, E., Steffen, B., Zukunft, S., Platzbecker, U., Ho, A.D., Baldus, C.D., Serve, H., Müller-Tidow, C., Thiede, C., Bornhäuser, M., Montesinos, P., Röllig, C. and Schlenk, R.F.
Haematologica 108 (8): 2059-2066. August 2023

Small molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy.
Demel, U.M. ORCID: https://orcid.org/0000-0002-6480-4185, Wirth, M. ORCID: https://orcid.org/0000-0002-8340-0872, Yousefian, S. ORCID: https://orcid.org/0000-0003-0902-0369, Zhang, L., Isaakidis, K., Dönig, J., Böger, M. ORCID: https://orcid.org/0000-0001-9301-5022, Singh, N., Köse, H., Haas, S. ORCID: https://orcid.org/0000-0001-9227-2051, Müller, S., Schick, M. ORCID: https://orcid.org/0009-0003-8626-0611 and Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958
Haematologica 108 (2): 555-567. February 2023

Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide - an international collaborative study.
Kayser, S., Schlenk, R.F., Lebon, D., Carre, M., Götze, K.S., Stölzel, F., Berceanu, A., Schäfer-Eckart, K., Peterlin, P., Hicheri, Y., Rahme, R., Raffoux, E., Chermat, F., Krause, S.W., Aulitzky, W.E., Rigaudeau, S., Noppeney, R., Berthon, C., Görner, M., Jost, E., Carassou, P., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Orvain, C., Braun, T., Saillard, C., Arar, A., Kunzmann, V., Wemeau, M., De Wit, M., Niemann, D., Bonmati, C., Schwänen, C., Abraham, J., Aljijakli, A., Haiat, S., Krämer, A., Reichle, A., Gnadler, M., Willekens, C., Spiekermann, K., Hiddemann, W., Müller-Tidow, C., Thiede, C., Röllig, C., Serve, H., Bornhäuser, M., Baldus, C.D., Lengfelder, E., Fenaux, P., Platzbecker, U. and Adès, L.
Haematologica 106 (12): 3100-3106. December 2021

A CD205-directed antibody drug conjugate - lymphoma precision oncology or sophisticated chemotherapy?
Rieke, D.T. and Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958
Haematologica 105 (11): 2504-2506. 1 November 2020

HemaSphere

Clinical implications and dynamics of clonal hematopoiesis in anti-CD19 CAR T-cell treated patients.
Panagiota, V., Kerschbaum, J.F., Penack, O., Stein, C.M., Arends, C.M., Koenecke, C., Strzelecka, P.M. ORCID: https://orcid.org/0000-0003-0226-6788, Kloos, A., Wiegand, L., Lasch, A., Altwasser, R. ORCID: https://orcid.org/0009-0002-6216-6068, Halik, A., Gabdoulline, R., Thomson, J., Weibl, K., Franke, G.N., Berger, C., Hasenkamp, J., Ayuk, F., Na, I.K. ORCID: https://orcid.org/0000-0001-9902-5424, Beutel, G., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Wulf, G.G., Kröger, N., Vucinic, V., Heuser, M. and Damm, F.
HemaSphere 7 (10): e957. October 2023

Radiation and dose-densification of R-CHOP in aggressive B-cell lymphoma with intermediate prognosis: the UNFOLDER study.
Thurner, Lorenz, Ziepert, Marita, Berdel, Christian, Schmidt, Christian, Borchmann, Peter, Kaddu-Mulindwa, Dominic, Viardot, Andreas, Witzens-Harig, Mathias, Dierlamm, Judith, Haenel, Mathias, Metzner, Bernd, Wulf, Gerald, Lengfelder, Eva, Keller, Ulrich B. ORCID: https://orcid.org/0000-0002-8485-1958, Frickhofen, Norbert, Nickelsen, Maike, Gaska, Tobias, Griesinger, Frank, Mahlberg, Rolf, Marks, Reinhard, Shpilberg, Ofer, Lindemann, Hans-Walter, Soekler, Martin, Fischer von Weikersthal, Ludwig, Kiehl, Michael, Roemer, Eva, Bentz, Martin, Krammer-Steiner, Beate, Trappe, Ralf, de Nully Brown, Peter, Federico, Massimo, Merli, Francesco, Engelhard, Marianne, Glass, Bertram, Schmitz, Norbert, Truemper, Lorenz, Bewarder, Moritz, Hartmann, Frank, Murawski, Niels, Stilgenbauer, Stephan, Rosenwald, Andreas, Altmann, Bettina, Schmidberger, Heinz, Fleckenstein, Jochen, Loeffler, Markus, Poeschel, Viola and Held, Gerhard
HemaSphere 7 (7): e904. July 2023

Genotype and intensive pretreatment influence outcome of acute myeloid leukemia patients treated with venetoclax in combination with hypomethylating agents or low-dose cytarabine: "real world" data from germany.
Braitsch, K., Schmalbrock, L.K. ORCID: https://orcid.org/0000-0002-6080-6175, Jung, P., Bumeder, I., Kiewe, P., Hecker, J.S., Verbeek, M., Westermann, J., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Bassermann, F., Krönke, J., Götze, K.S. and Rieger, K.
HemaSphere 6 (9): e759. September 2022

The mTOR inhibitor temsirolimus added to rituximab combined with dexamethasone, cytarabine, and cisplatinum (R-DHAP) for the treatment of patients with relapsed or refractory DLBCL - results from the phase-II STORM trial.
Witzens-Harig, M., Viardot, A., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Wosniok, J., Deuster, O., Klemmer, J., Geueke, A.M., Meißner, J., Ho, A.D., Atta, J., Marks, R., La Rosée, P., Buske, C., Dreyling, M.H. and Hess, G.
HemaSphere 5 (10): e636. October 2021

Final results of a phase I/II trial of the combination Bendamustine and Rituximab with Temsirolimus (BeRT) in relapsed mantle cell lymphoma and follicular lymphoma.
Hess, G., Wagner, K., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, La Rosee, P., Atta, J., Hübel, K., Lerchenmueller, C., Schoendube, D., Witzens-Harig, M., Ruckes, C., Medler, C., van Oordt, C., Klapper, W., Theobald, M. and Dreyling, M.
HemaSphere 4 (3): e398. June 2020

International Journal of Molecular Sciences

Target selection for T-cell therapy in epithelial ovarian cancer: systematic prioritization of self-antigens.
Schossig, P. ORCID: https://orcid.org/0000-0001-5017-3602, Coskun, E., Arsenic, R., Horst, D., Sehouli, J. ORCID: https://orcid.org/0000-0002-5963-6623, Bergmann, E., Andresen, N., Sigler, C. ORCID: https://orcid.org/0000-0003-3229-4122, Busse, A. ORCID: https://orcid.org/0000-0002-3470-6947, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Ochsenreither, S. ORCID: https://orcid.org/0000-0001-6024-4312
International Journal of Molecular Sciences 24 (3): 2292. 24 January 2023

JACC: CardioOncology

Growth differentiation factor-15: a promising biomarker and target in cancer patients.
Anker, M., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Khan, M.S.
JACC: CardioOncology 7 (2): 153-156. February 2025

JAMA Network Open

Leveraging large language models for decision support in personalized oncology.
Benary, M. ORCID: https://orcid.org/0000-0002-3067-2030, Wang, X.D., Schmidt, M., Soll, D., Hilfenhaus, G. ORCID: https://orcid.org/0000-0001-8764-077X, Nassir, M., Sigler, C., Knödler, M., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Beule, D. ORCID: https://orcid.org/0000-0002-3284-0632, Keilholz, U., Leser, U. and Rieke, D.T.
JAMA Network Open 6 (11): e2343689. November 2023

JAMA Oncology

Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial.
Bröckelmann, P.J., Goergen, H., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Meissner, J., Ordemann, R., Halbsguth, T.V., Sasse, S., Sökler, M., Kerkhoff, A., Mathas, S. ORCID: https://orcid.org/0000-0001-9626-1413, Hüttmann, A., Bormann, M., Zimmermann, A., Mettler, J., Fuchs, M., von Tresckow, B., Baues, C., Rosenwald, A., Klapper, W., Kobe, C., Borchmann, P. and Engert, A.
JAMA Oncology 6 (6): 872-880. June 2020

Journal for ImmunoTherapy of Cancer

High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies.
Çınar, Ö. ORCID: https://orcid.org/0000-0001-5297-127X, Brzezicha, B., Grunert, C. ORCID: https://orcid.org/0000-0001-8376-8629, Kloetzel, P.M., Beier, C., Peuker, C.A. ORCID: https://orcid.org/0000-0002-0957-2166, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Pezzutto, A. ORCID: https://orcid.org/0000-0002-3246-4470 and Busse, A. ORCID: https://orcid.org/0000-0002-3470-6947
Journal for ImmunoTherapy of Cancer 9 (7): e002410. 30 July 2021

Journal of Cachexia Sarcopenia and Muscle

The prognostic role of frailty and its recognition with simple FRAIL and fried frailty questionnaires in advanced cancer patients.
Weinländer, Pia, Hadzibegovic, Sara, Porthun, Jan, Kretzler, Lucie, Evertz, Ruben, Lena, Alessia, Lück, Laura-Carina, Hella, Jonathan L, Wilkenshoff, Ursula, Stroux, Andrea, Keramida, Kalliopi, Letsch, Anne, Modest, Dominik Paul, Bullinger, Lars ORCID: https://orcid.org/0000-0002-5890-5510, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Karakas, Mahir, Abdelwahed, Youssef S., Attanasio, Philipp, Rauch, Ursula, Skurk, Carsten, Doehner, Wolfram, Landmesser, Ulf, von Haehling, Stephan and Anker, Markus S.
Journal of Cachexia Sarcopenia and Muscle 16 (5): e70076. October 2025

Hand grip strength in patients with advanced cancer: a prospective study.
Hadzibegovic, S., Porthun, J., Lena, A., Weinlaänder, P., Lück, L.C., Potthoff, S.K., Rösnick, L., Fröhlich, A.K., Ramer, L.V., Sonntag, F., Wilkenshoff, U., Ahn, J., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Mahabadi, A.A., Totzeck, M., Rassaf, T., von Haehling, S., Coats, A.J.S., Anker, S.D., Roeland, E.J., Landmesser, U. and Anker, M.S. ORCID: https://orcid.org/0000-0002-4406-8555
Journal of Cachexia Sarcopenia and Muscle 14 (4): 1682-1694. August 2023

Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancer.
Anker, M.S. ORCID: https://orcid.org/0000-0002-4406-8555, Lena, A., Roeland, E.J., Porthun, J., Schmitz, S., Hadzibegovic, S., Sikorski, P., Wilkenshoff, U., Fröhlich, A.K., Ramer, L.V., Rose, M., Eucker, J., Rassaf, T., Totzeck, M., Lehmann, L.H., von Haehling, S., Coats, A.J.S., Friede, T. ORCID: https://orcid.org/0000-0001-5347-7441, Butler, J., Anker, S.D., Riess, H., Landmesser, U., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Ahn, J.
Journal of Cachexia Sarcopenia and Muscle 14 (4): 1670-1681. August 2023

Journal of Clinical Investigation

GP130 activation induces myeloma and collaborates with MYC.
Dechow, T., Steidle, S., Götze, K.S., Rudelius, M., Behnke, K., Pechloff, K., Kratzat, S., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Fend, F., Soberon, V., Mitova, N., Li, Z., Thaler, M., Bauer, J., Pietschmann, E., Albers, C., Grundler, R., Schmidt-Supprian, M., Ruland, J., Peschel, C., Duyster, J., Rose-John, S., Bassermann, F. and Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958
Journal of Clinical Investigation 124 (12): 5263-5274. 1 December 2014

Journal of Clinical Oncology

(90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial.
Scholz, C.W., Pinto, A., Linkesch, W., Lindén, O., Viardot, A., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Hess, G., Lastoria, S., Lerch, K., Frigeri, F., Arcamone, M., Stroux, A., Frericks, B., Pott, C. and Pezzutto, A. ORCID: https://orcid.org/0000-0002-3246-4470
Journal of Clinical Oncology 31 (3): 308-313. 20 January 2013

Journal of Neuro-Oncology

Clinical characteristics and outcomes in leptomeningeal disease with or without brain metastasis: insights from an explorative data analysis of the Charité LMD registry.
Wasilewski, D., Eitner, C., Ates, R., Murad, S., Shaked, Z., Steinle, J.A., Wetzel-Yalelis, A., Sargut, T.A., Rösler, J., Samman, M.A., Truckenmüller, P., Mertens, R., Kroneberg, D., Kowski, A., Radbruch, H. ORCID: https://orcid.org/0000-0001-6941-3397, Capper, D., Ehret, F., Roohani, S., Frost, N., Nawabi, J., Onken, J., Schlaak, M., Blohmer, J.U., Pelzer, U., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Sehouli, J., Vajkoczy, P., Keilholz, U. and Misch, M.
Journal of Neuro-Oncology 175 (3): 943-965. December 2025

Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions – results from the European M2Spine study group.
Hubertus, Vanessa, Viezens, Lennart, Stangenberg, Martin, Früh, Anton M., Meyer, Hanno S., Liang, Raimunde, Kramer, Andreas, Orban, Christoph, Kerschbaumer, Johannes, Kunze, Beate, Telera, Stefano, Miller, Hannah, Entenmann, Christian J., von Bronewski, Emily J., Buhre, Charlotte, Leonhardt, Leon-Gordian, Willenbacher, Wolfgang, Kvitsaridze, Irma, Laue, Dominik, Pumberger, Matthias, Keller, Theresa, Acker, Güliz, Krönke, Jan, Blau, Igor-Wolfgang, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Ringel, Florian, Thomé, Claudius, Meyer, Bernhard, Vajkoczy, Peter, Dreimann, Marc and Onken, Julia Sophie
Journal of Neuro-Oncology 174 (3): 765-777. September 2025

Journal of Nuclear Medicine

CXCR4-targeted PET imaging of central nervous system B-cell lymphoma.
Herhaus, P., Lipkova, J., Lammer, F., Yakushev, I., Vag, T., Slotta-Huspenina, J., Habringer, S. ORCID: https://orcid.org/0000-0002-3976-9592, Lapa, C., Pukrop, T., Hellwig, D., Wiestler, B., Buck, A.K., Deckert, M., Wester, H.J., Bassermann, F., Schwaiger, M., Weber, W.A., Menze, B. and Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958
Journal of Nuclear Medicine 61 (12): 1765-1771. 1 December 2020

Journal of the American College of Cardiology

Clinical and prognostic relevance of cardiac wasting in patients with advanced cancer.
Lena, A., Wilkenshoff, U., Hadzibegovic, S., Porthun, J., Rösnick, L., Fröhlich, A.K., Zeller, T., Karakas, M., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Ahn, J., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Riess, H., Rosen, S.D., Lyon, A.R., Lüscher, T.F., Totzeck, M., Rassaf, T., Burkhoff, D., Mehra, M.R., Bax, J.J., Butler, J., Edelmann, F., Haverkamp, W., Anker, S.D., Packer, M., Coats, A.J.S., von Haehling, S., Landmesser, U. and Anker, M.S.
Journal of the American College of Cardiology 81 (16): 1569-1586. 25 April 2023

Lancet Haematology

PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.
Kreissl, S., Goergen, H., Buehnen, I., Kobe, C., Moccia, A., Greil, R., Eichenauer, D.A., Zijlstra, J.M., Markova, J., Meissner, J., Feuring-Buske, M., Soekler, M., Beck, H.J., Willenbacher, W., Ludwig, W.D., Pabst, T., Topp, M.S., Hitz, F., Bentz, M., Keller, U.B. ORCID: https://orcid.org/0000-0002-8485-1958, Kühnhardt, D., Ostermann, H., Hertenstein, B., Aulitzky, W., Maschmeyer, G., Vieler, T., Eich, H., Baues, C., Stein, H., Fuchs, M., Diehl, V., Dietlein, M., Engert, A. and Borchmann, P.
Lancet Haematology 8 (6): e398-e409. June 2021

Lancet Oncology

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Borchmann, P., Plütschow, A., Kobe, C., Greil, R., Meissner, J., Topp, M.S., Ostermann, H., Dierlamm, J., Mohm, J., Thiemer, J., Sökler, M., Kerkhoff, A., Ahlborn, M., Halbsguth, T.V., Martin, S., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Balabanov, S., Pabst, T., Vogelhuber, M., Hüttmann, A., Wilhelm, M., Zijlstra, J.M., Moccia, A., Kuhnert, G., Bröckelmann, P.J., von Tresckow, B., Fuchs, M., Klimm, B., Rosenwald, A., Eich, H., Baues, C., Marnitz, S., Hallek, M., Diehl, V., Dietlein, M. and Engert, A.
Lancet Oncology 22 (2): 223-234. February 2021

Leukemia

Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid.
Weinschenk, S, Philipp, U, Kuehn, J C, Mueller, K, Fauser, J, Boeckle, D, Gebhard, I, Hinz, M, Neidert, N, Bleul, S, Lauer, E M, Mutter, J A, Alig, S K, Kurtz, D M, Finke, J, Marks, R, Diehn, M, Alizadeh, A A, Reinacher, P C, Wehrle, J, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Wolf, D, Kocher, F, Chapuy, B, Beck, J, Prinz, M, von Baumgarten, L, Schorb, E, Duyster, J and Scherer, F
Leukemia 39 (5): 1265-1268. May 2025

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Ferreri, A.J.M. ORCID: https://orcid.org/0000-0001-9606-6124, Cwynarski, K. ORCID: https://orcid.org/0000-0001-9936-3431, Pulczynski, E., Fox, C.P., Schorb, E., Celico, C., Falautano, M., Nonis, A., La Rosée, P. ORCID: https://orcid.org/0000-0002-6758-7809, Binder, M., Fabbri, A., Ilariucci, F., Krampera, M. ORCID: https://orcid.org/0000-0002-7280-2040, Roth, Al., Hemmaway, C., Johnson, P.W., Linton, K.M., Pukrop, T., Gørløv, J.S., Balzarotti, M., Hess, G. ORCID: https://orcid.org/0000-0002-9282-5688, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Stilgenbauer, S., Panse, J. ORCID: https://orcid.org/0000-0001-6316-3112, Tucci, A. ORCID: https://orcid.org/0000-0003-3052-7463, Orsucci, L., Pisani, F., Zanni, M., Krause, S.W. ORCID: https://orcid.org/0000-0002-5259-4651, Schmoll, H.J., Hertenstein, B., Rummel, M., Smith, J., Thurner, L., Cabras, G., Pennese, E., Ponzoni, M., Deckert, M., Politi, L.S., Finke, J. ORCID: https://orcid.org/0000-0002-1799-5927, Ferranti, A., Cozens, K., Burger, E., Ielmini, N., Cavalli, F., Zucca, E. ORCID: https://orcid.org/0000-0002-5522-6109 and Illerhaus, G.
Leukemia 36 (7): 1870-1878. July 2022

Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL network phase II trial.
Ferrero, S., Pastore, A., Scholz, C.W., Forstpointner, R., Pezzutto, A. ORCID: https://orcid.org/0000-0002-3246-4470, Bergmann, L., Truemper, L., Finke, J., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Ghione, P., Passera, R., Hiddemann, W., Weigert, O., Unterhalt, M. and Dreyling, M.
Leukemia 30 (4): 984-987. April 2016

Leukemia & Lymphoma

Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial.
Kaddu-Mulindwa, D. ORCID: https://orcid.org/0000-0001-8832-252X, Lesan, V., Berdel, C., Stilgenbauer, S., Bewarder, M., Thurner, L., Witzens-Harig, M., Viardot, A. ORCID: https://orcid.org/0000-0001-9593-6327, Soekler, M., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Truemper, L., Christofyllakis, K., Fleser, O., Bittenbring, J.T., Poeschel, V., Held, G. and Jagoda, P.
Leukemia & Lymphoma 63 (2): 326-334. February 2022

Leukemia Research

In vitro testing of drug response in primary multiple myeloma cells using a microwell-based technology.
Krüger, J., Blau, I.W., Blau, O., Bettelli, A., Rocchi, L., Bocchi, M., Krönke, J., Bullinger, L. ORCID: https://orcid.org/0000-0002-5890-5510, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Nogai, A.
Leukemia Research 147 : 107599. December 2024

MedComm

The protein phosphatase inhibitor LB100 targets the mesenchymal lineage of pancreatic ductal adenocarcinoma.
Murr, Janine, Schneider, Carolin, Duan, Ningjun, Köse, Hazal, Rajamani, Anantharamanan, He, Xueyang, Buchloh, Jonas, Hintze, Christian, Naik, Atharva, Goeke, Daniel, Rjasanow, Nicole, Krauß, Lukas, Nguyen, Alexandra, Widholz, Sebastian A., Schneeweis, Christian, Trozzo, Riccardo, Orben, Felix, Mueller, Sebastian, Öllinger, Rupert, Montero, Juan J., Dudek, Michael, Knolle, Percy, Kong, Bo, Ellenrieder, Volker, Contreras, Constanza Tapia, Hessmann, Elisabeth, Grade, Marian, Ghadimi, Michael, Braun, Christian J., Rad, Roland, Reichert, Maximillian, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Schmid, Roland M., Boutz, Paul L., Saur, Dieter, Wirth, Matthias ORCID: https://orcid.org/0000-0002-8340-0872, Krämer, Oliver H. and Schneider, Günter ORCID: https://orcid.org/0000-0003-1840-4508
MedComm 7 (6): e70794. June 2026

Medical Image Analysis

Towards quantitative imaging biomarkers of tumor dissemination: a multi-scale parametric modeling of multiple myeloma.
Piraud, M., Wennmann, M., Kintzelé, L., Hillengass, J., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Langs, G., Weber, M.A. and Menze, B.H.
Medical Image Analysis 57 : 214-225. October 2019

Methods in Molecular Biology

Gene gun Her2/neu DNA vaccination: evaluation of vaccine efficacy in a syngeneic Her2/neu mouse tumor model.
Nguyen-Hoai, T., Hohn, O., Pezzutto, A. ORCID: https://orcid.org/0000-0002-3246-4470 and Westermann, J.
Methods in Molecular Biology 2521 (3): 129-154. 23 June 2022

TCR gene therapy for cancer.
Rhein, S. ORCID: https://orcid.org/0000-0002-9445-2352 and Çakmak-Görür, N. ORCID: https://orcid.org/0000-0001-7857-2461
Methods in Molecular Biology 2521 (3): 95-128. 23 June 2022

Molecular & Cellular Proteomics

Molecular Cancer Therapeutics

Molecular Cell

The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma.
Heider, M., Eichner, R., Stroh, J., Morath, V., Kuisl, A., Zecha, J., Lawatscheck, J., Baek, K., Garz, A.K., Rudelius, M., Deuschle, F.C., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Lemeer, S., Verbeek, M., Götze, K.S., Skerra, A., Weber, W.A., Buchner, J., Schulman, B.A., Kuster, B., Fernández-Sáiz, V. and Bassermann, F.
Molecular Cell 81 (6): 1170-1186. 18 March 2021

Molecular Oncology

Targeting the ubiquitin-proteasome system in a pancreatic cancer subtype with hyperactive MYC.
Lankes, K., Hassan, Z.Z., Doffo, M.J., Schneeweis, C., Lier, S., Öllinger, R., Rad, R., Krämer, O.H., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Saur, D., Reichert, M., Schneider, G. and Wirth, M. ORCID: https://orcid.org/0000-0002-8340-0872
Molecular Oncology 14 (12): 3048-3064. December 2020

Nature

Nature Cancer

Nature Communications

Nature Methods

Segment anything for microscopy.
Archit, A. ORCID: https://orcid.org/0009-0002-9533-8620, Freckmann, L., Nair, S., Khalid, N. ORCID: https://orcid.org/0000-0001-9274-3757, Hilt, P., Rajashekar, V., Freitag, M. ORCID: https://orcid.org/0009-0005-0920-2535, Teuber, C. ORCID: https://orcid.org/0009-0004-3866-191X, Spitzner, M., Tapia Contreras, C., Buckley, G. ORCID: https://orcid.org/0000-0003-2763-492X, von Haaren, S., Gupta, S., Grade, M., Wirth, M. ORCID: https://orcid.org/0000-0002-8340-0872, Schneider, G., Dengel, A., Ahmed, S. and Pape, C. ORCID: https://orcid.org/0000-0001-6562-7187
Nature Methods 22 (3): 579-591. March 2025

New England Journal of Medicine

Teclistamab-induced remission in refractory systemic lupus erythematosus.
Alexander, T. ORCID: https://orcid.org/0000-0003-1193-0097, Krönke, J., Cheng, Q., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Krönke, G.
New England Journal of Medicine 391 (9): 864-866. 5 September 2024

Nuklearmedizin

CXCR4-gerichtete Theranostics in der Hämato-Onkologie: Möglichkeiten und Herausforderungen [CXCR4-targeted theranostics in hematooncology: opportunities and challenges].
Werner, R., Haug, A., Buske, C., Heidegger, S., Illert, A.L., Bassermann, F., Herhaus, P., Buck, A., Duell, J., Topp, M.S., Kraus, S., Einsele, H., Lapa, C., Raderer, M., Lenz, G., Habringer, S., von Tresckow, B. and Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958
Nuklearmedizin 63 (2): 57-61. April 2024

Oncologist

Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLC.
Rosnev, Stanislav ORCID: https://orcid.org/0000-0003-0256-7038, Klein, Katharina, Heukamp, Lukas, Lenk, Julian, Joosten, Maria, Möbs, Markus ORCID: https://orcid.org/0000-0002-1502-3032, Grob, Tobias, Benary, Manuela ORCID: https://orcid.org/0000-0002-3067-2030, Vecchione, Loredana, Ott, Claus-Eric ORCID: https://orcid.org/0000-0003-3627-3791, Modest, Dominik P., Knödler, Maren, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Frost, Nikolaj ORCID: https://orcid.org/0000-0001-7452-7129, Keilholz, Ulrich, Kiewe, Philipp and Rieke, Damian T. ORCID: https://orcid.org/0000-0003-0027-7977
Oncologist 31 (6): oyag151. June 2026

Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patient.
Rieke, Damian T. ORCID: https://orcid.org/0000-0003-0027-7977, Schwartz, Stefan, Ochsenreither, Sebastian, Chapuy, Björn, Amthauer, Holger, Deubzer, Hedwig E. ORCID: https://orcid.org/0000-0002-6115-4893, Lehmann, Annika, Keilholz, Ulrich, Wardelmann, Eva, Vokuhl, Christian, Eggert, Angelika, Fröhling, Stefan, Horst, David, Capper, David ORCID: https://orcid.org/0000-0003-1945-497X, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Dragomir, Mihnea P. and Schallenberg, Simon ORCID: https://orcid.org/0000-0002-7897-7116
Oncologist 31 (5): oyag132. May 2026

Oncology Research and Treatment

Variable outcomes of hepatitis E infections in patients with hemato-oncologic diseases.
Ingwersen, V., Hofmann, J., Muche, M., Le Coutre, P., Schneider, T., Leng, C., Burmeister, T., Maschmeyer, G., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Schwartz, S.
Oncology Research and Treatment 46 (7-8): 296-302. August 2023

Oncotarget

Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer.
Klinghammer, K. ORCID: https://orcid.org/0000-0001-6425-4833, Politz, O., Eder, T., Otto, R., Raguse, J.D., Albers, A., Kaufmann, A., Tinhofer, I., Hoffmann, J. ORCID: https://orcid.org/0000-0003-3880-1658, Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Keilholz, U.
Oncotarget 11 (41): 3688-3697. 13 October 2020

Oral Oncology

Molecular subtyping of head and neck cancer - Clinical applicability and correlations with morphological characteristics.
Stögbauer, F., Otto, R., Jöhrens, K., Tinhofer, I., Keilholz, U., Poremba, C., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Leser, U., Weichert, W., Boxberg, M. ORCID: https://orcid.org/0000-0001-5989-7922 and Klinghammer, K. ORCID: https://orcid.org/0000-0001-6425-4833
Oral Oncology 149 : 106678. February 2024

Proceedings of the National Academy of Sciences of the United States of America

Science Signaling

Scientific Reports

Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment.
Burmeister, T., Gröger, D., Gökbuget, N., Spriewald, B., Starck, M., Elmaagacli, A., Hoelzer, D., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Schwartz, S.
Scientific Reports 13 (1): 15167. 13 September 2023

Predictors of lower exercise capacity in patients with cancer.
Evertz, R. ORCID: https://orcid.org/0000-0002-5904-4652, Diehl, C., Gödde, K., Valentova, M., Garfias-Veitl, T., Overbeck, T.R., Braulke, F., Lena, A., Hadzibegovic, S., Bleckmann, A., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Landmesser, U., König, A.O., Hasenfuss, G., Schuster, A. ORCID: https://orcid.org/0000-0003-1508-1125, Anker, M.S. and von Haehling, S.
Scientific Reports 13 (1): 14861. 8 September 2023

Springer Reference Medizin

Abklärung und OP-Indikationen bei malignen Lymphknoten des unteren GI-Traktes.
Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958 and Merz, I.
In: Chirurgie des unteren Gastrointestinaltrakts und Allgemeine Chirurgie. Springer Reference Medizin . Springer, Berlin, Heidelberg, 177-185. ISBN 978-3-662-63355-7 31 July 2024

Theranostics

Reduced splenic uptake on (68)Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis.
Kraus, S., Klassen, P., Kircher, M., Dierks, A., Habringer, S. ORCID: https://orcid.org/0000-0002-3976-9592, Gäble, A., Kortüm, K.M., Weinhold, N., Ademaj-Kospiri, V., Werner, R.A., Schirbel, A., Buck, A.K., Herhaus, P., Wester, H.J., Rosenwald, A., Weber, W.A., Einsele, H., Keller, U. ORCID: https://orcid.org/0000-0002-8485-1958, Rasche, L. and Lapa, C.
Theranostics 12 (13): 5986-5994. 8 August 2022

Zenodo

npj Precision Oncology

Targetable alterations and personalized treatment in ameloblastoma: results from a prospective observational precision oncology study.
Hofmann, Elena, Abu-Sirhan, Shady, Elsholtz, Fabian, Piwonski, Iris, Kreutzer, Kilian, Doll, Christian, Joosten, Maria, Möbs, Markus, Busch, Chia-Jung, Fenske, Benjamin, Knödler, Maren, Pestana, Ana, Hirschhorn, Ariel, Heiland, Max, Keller, Ulrich ORCID: https://orcid.org/0000-0002-8485-1958, Keilholz, Ulrich, Klinghammer, Konrad ORCID: https://orcid.org/0000-0001-6425-4833, Rieke, Damian T. and Schmidt, Max
npj Precision Oncology 10 (1): 217. 12 June 2026

This list was generated on Sun Jul 12 18:24:39 2026 UTC.